JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was THB 436.45 million compared to THB 429.13 million a year ago. Net loss was THB 17.48 million compared to net income of THB 29.69 million a year ago.

Basic loss per share from continuing operations was THB 0.04 compared to basic earnings per share from continuing operations of THB 0.08 a year ago. Diluted loss per share from continuing operations was THB 0.04 compared to diluted earnings per share from continuing operations of THB 0.08 a year ago.